Vaginal Pessary Versus Expectant Management for Placenta Previa
Vaginal Pessary Versus Expectant Management for the Prevention of Delivery Prior to 36 Weeks in Women With Placenta Previa
Sponsor: Obstetrix Medical Group
Terminated
Study was terminated early do to a business decision by sponsor and lack of ability to recruit the needed number of participants.
Other terminated trials from Obstetrix Medical Group
More terminations from Obstetrix Medical Group
A NA clinical study on Placenta Previa, this trial is terminated or withdrawn. The trial is conducted by Obstetrix Medical Group and has accumulated 13 data snapshots since 2016. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
13 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Feb 2023 — Jul 2024 [monthly]
Terminated NA
-
Dec 2021 — Feb 2023 [monthly]
Terminated NA
-
Jan 2021 — Dec 2021 [monthly]
Terminated NA
▶ Show 8 earlier versions
-
Nov 2020 — Jan 2021 [monthly]
Terminated NA
-
Oct 2018 — Nov 2020 [monthly]
Terminated NA
Status: Active Not Recruiting → Terminated
-
Jul 2018 — Oct 2018 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Jun 2018 — Jul 2018 [monthly]
Recruiting NA
-
Mar 2018 — Jun 2018 [monthly]
Recruiting NA
-
Feb 2018 — Mar 2018 [monthly]
Recruiting NA
-
Feb 2017 — Feb 2018 [monthly]
Recruiting NA
-
Jan 2017 — Feb 2017 [monthly]
Recruiting NA
First recorded
Oct 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Obstetrix Medical Group
- Pediatrix
For direct contact, visit the study record on ClinicalTrials.gov .